Indication

Stevens-Johnson syndrome

Stevens-Johnson syndrome is an acute, life-threatening type IV mucocutaneous hypersensitivity reaction characterized by extensive keratinocyte apoptosis, leading to epidermal detachment and mucosal sloughing. Read more about Stevens-Johnson syndrome

48 drugs 35 manufacturers

Advertisement

Drugs that treat it

Common Stevens-Johnson syndrome therapies.

Showing 19–27 of 48 drugs

PREDNISOLONE

GLUCOCORTICOSTEROIDS·TRICHINOSIS·+59
PHARMACEU ASSOC
Filter & compare in the drug finder →Opens the drug finder with Stevens-Johnson syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Stevens-Johnson syndrome.

Stevens-Johnson syndrome is an acute, life-threatening type IV mucocutaneous hypersensitivity reaction characterized by extensive keratinocyte apoptosis, leading to epidermal detachment and mucosal sloughing.

Representing the less extensive presentation along a shared disease spectrum with toxic epidermal necrolysis, it specifically features epidermal necrosis and detachment involving less than 10% of the total body surface area.

The condition predominantly affects adults—particularly individuals with specific human leukocyte antigen variants or underlying immunodeficiency—and typically presents with a systemic flu-like prodrome followed by painful coalescing macules, bullae, and painful erosions involving at least two mucosal sites, most commonly the oral cavity, ocular conjunctiva, and genitalia.

Personalize your experience

Follow Stevens-Johnson syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it